The Pipeline and Hazardous Materials Safety Administration (PHMSA) has announced a significant adjustment to its drug testing protocols for the pipeline industry in 2025. Effective January 1, 2025, the minimum annual random drug testing rate for covered employees will increase from 25% to 50%.
Understanding the Change
PHMSA's regulations mandate that operators of gas, hazardous liquid, and carbon dioxide pipeline facilities, as well as liquefied natural gas (LNG) plants and underground natural gas storage facilities, conduct random drug tests on employees performing safety-sensitive functions. The frequency of these tests is determined by the industry's overall positive test rates. Specifically, if the positive rate exceeds 1% in a calendar year, PHMSA is required to increase the minimum testing rate to 50%.
Data from the Drug and Alcohol Management Information System (DAMIS) for the calendar year 2023 revealed a random drug testing positive rate greater than 1%. Consequently, PHMSA is implementing the increased testing rate to enhance safety and compliance within the industry.
Implications for Employers
This adjustment means that, starting in 2025, operators must ensure that at least half of their covered employees are selected randomly for drug testing throughout the year. This increase aims to deter drug use and promote a safer working environment.
Employers should review and, if necessary, update their drug testing policies and procedures to align with the new requirements. This includes ensuring that random selection processes are truly random and that all covered employees have an equal chance of being tested. Additionally, maintaining accurate records of testing activities is crucial for compliance and potential audits.
Multi-Factor Authentication for DAMIS Reporting
In addition to the increased testing rate, PHMSA will continue to utilize Multi-Factor Authentication (MFA) for accessing the DAMIS database. This measure enhances the security of sensitive data related to drug and alcohol testing. Operators and contractors must ensure that their personnel responsible for submitting DAMIS reports are equipped to comply with MFA requirements.
How DISA Can Help
Navigating regulatory changes can be challenging, but DISA Global Solutions is here to assist. With extensive experience in employment screening and compliance, DISA offers comprehensive drug and alcohol testing programs tailored to meet PHMSA requirements. Our services include random drug testing management, policy development, and assistance with DAMIS reporting, ensuring that your organization remains compliant and operates safely. Partnering with DISA provides access to industry expertise and resources designed to streamline compliance processes, allowing you to focus on your core operations.